Which cells secrete DKK1 and SFRPs in multiple myeloma to influence bone remodeling?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $24.99Unlock all

Study for the Mandible, TMJ, Bone Modeling Test. Enhance your knowledge with diverse questions, explanations, and hints. Prepare confidently for your successful exam attempt!

Multiple Choice

Which cells secrete DKK1 and SFRPs in multiple myeloma to influence bone remodeling?

Explanation:
In this context, the main idea is how myeloma cells disrupt bone formation. Malignant plasma cells in multiple myeloma secrete inhibitors of the Wnt signaling pathway, specifically DKK1 and secreted frizzled-related proteins (SFRPs). Wnt signaling promotes osteoblast differentiation and bone formation, so when DKK1 and SFRPs block this pathway, osteoblast activity decreases. That shift reduces new bone formation and contributes to the characteristic osteolytic lesions of multiple myeloma. So the cells responsible for releasing these inhibitors are the myeloma cells themselves, not the osteoblasts, osteoclasts, or fibroblasts.

In this context, the main idea is how myeloma cells disrupt bone formation. Malignant plasma cells in multiple myeloma secrete inhibitors of the Wnt signaling pathway, specifically DKK1 and secreted frizzled-related proteins (SFRPs). Wnt signaling promotes osteoblast differentiation and bone formation, so when DKK1 and SFRPs block this pathway, osteoblast activity decreases. That shift reduces new bone formation and contributes to the characteristic osteolytic lesions of multiple myeloma. So the cells responsible for releasing these inhibitors are the myeloma cells themselves, not the osteoblasts, osteoclasts, or fibroblasts.

More Multiple Choice Questions
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy